[Fundamental and clinical evaluation of IRMA for serum SPan-1 antigen].
Fukuda
Y
Y
Department of Nuclear Medicine, Hyogo College of Medicine.
Murakami
M
M
Fukuchi
M
M
D002759:Adenoma, Bile Duct / Q000175:diagnosis / Q000276:immunology; D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D001650:Bile Duct Neoplasms / Q000175:diagnosis / Q000276:immunology; D014408:Biomarkers, Tumor / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005260:Female; D006801:Humans; D015592:Immunoradiometric Assay; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000276:immunology; D012015:Reference Standards
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; C059729:pancreatic associated antigen, SPan-1